I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| pericyte | 9 studies | 24% ± 7% | |
| smooth muscle cell | 8 studies | 23% ± 9% | |
| epithelial cell | 8 studies | 35% ± 19% | |
| CD8-positive, alpha-beta T cell | 7 studies | 30% ± 10% | |
| enterocyte | 6 studies | 27% ± 9% | |
| transit amplifying cell | 6 studies | 38% ± 19% | |
| abnormal cell | 6 studies | 23% ± 6% | |
| plasmablast | 5 studies | 38% ± 23% | |
| renal alpha-intercalated cell | 5 studies | 38% ± 15% | |
| goblet cell | 5 studies | 26% ± 5% | |
| T cell | 5 studies | 27% ± 7% | |
| natural killer cell | 5 studies | 31% ± 15% | |
| CD4-positive, alpha-beta T cell | 5 studies | 36% ± 10% | |
| B cell | 4 studies | 20% ± 4% | |
| deuterosomal cell | 4 studies | 30% ± 7% | |
| fibroblast | 4 studies | 24% ± 8% | |
| progenitor cell | 4 studies | 25% ± 9% | |
| connective tissue cell | 4 studies | 19% ± 3% | |
| intestinal crypt stem cell | 4 studies | 27% ± 8% | |
| brush cell | 4 studies | 26% ± 11% | |
| pancreatic A cell | 3 studies | 28% ± 7% | |
| mesothelial cell | 3 studies | 34% ± 13% | |
| pro-B cell | 3 studies | 22% ± 4% | |
| ciliated cell | 3 studies | 31% ± 5% | |
| Mueller cell | 3 studies | 37% ± 13% | |
| effector CD8-positive, alpha-beta T cell | 3 studies | 27% ± 4% | |
| regulatory T cell | 3 studies | 21% ± 6% |
